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Background: Uremic toxin, indoxyl sulfate (IS), may impair
proliferation and function of endothelial cells (ET) aswell as endothelial
progenitor cells (EPC). Nicotinic acid (niacin), a lipid-lowering drug, has
antioxidant effect. Methods & results: EPC were isolated from healthy
subjects and incubated with 1 mM IS. IS decreased the viability of EPC
by 34%, andwas restored by 1 mMniacin. IS did not induce apoptosis of
EPC, but increased autophage and senescence of EPC, which were all
restored by adding niacin. The ability ofmigration and tube formation of
EPC were 50% inhibited by IS. Niacin restored the migration of EPC by
40%, but not tube formation. IS signiﬁcantly increased ROS and heme
oxygenase-1 expression, and decreased the expression of eNOS and
VEGF. All these adverse effects of IS were antagonized by niacin.
Conclusion: Niacin had beneﬁcial effects on ET in uremic patients, in
addition to lipid-lowering effect, through its restoration of EPC function.
doi:10.1016/j.lfs.2013.12.135
Endothelin-1 does not alter macrophage phenotype
Rebecca C. Moorhousea, Neeraj Dhauna,b,
David J. Webba, David C. Kluthb
aCentre for Cardiovascular Science, Queen's Medical Research Institute,
University of Edinburgh, Edinburgh, UK
bCentre for Inﬂammation Research, Queen's Medical Research Institute,
University of Edinburgh, Edinburgh, UK
E-mail address: r.moorhouse@sms.ed.ac.uk (R.C. Moorhouse)
ET-1 and inﬂammation are involved in the pathogenesis of
hypertension. Macrophages, which are recruited to the inﬂamed
vasculature, express both endothelin-A and endothelin-B receptors.
Macrophages can also produce and release ET-1 but the precise effects of
ET-1 on macrophage phenotype are unclear. Bone marrow derived
macrophages (prepared from C57/BL6 mice) were stimulated for 24 h
with ET-1 (10–1000 pg/ml), LPS/INFγ (100 ng/ml and 10 ng/ml) and
IL4/IL13 (10 ng/ml). Cytokines (TNFα, IL 6 and IL 10) and ET-1 were
measured by ELISA and qRT-PCR and mRNA for iNOS, MCP-1, mannose
receptor and Arginase 1 by qRT-PCR. Whereas LPS/INFγ increased
production of TNFα, IL6 and IL10 and upregulated markers of classical
activation (iNOS and MCP-1) ET-1 did not. IL4/IL13 stimulation
upregulated markers of alternative activation (mannose receptor and
arginase 1) but ET-1 did not. In addition, ET-1 pre-treatment and co-
stimulation did not affect the response to LPS. In vitro ET-1 does not
activate macrophages to alter phenotype and also does not have a co-
stimulating effect with factors known to stimulate classical or alternative
activation. This suggests that ET-1 is not pro-inﬂammatory to macro-
phages and does not induce an alternative activation.
N= 4 repeated in triplicate, ⁎P b 0.001 compared to untreated control.
doi:10.1016/j.lfs.2013.12.136
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Background: Endothelin (ET) system plays a critical role in the
development of insulin resistance and type 2 diabetes. However, the
molecularmechanism for ET receptor (ETR) signaling activated by ET-1
in skeletal muscle remains to be determined. The purpose of this study
was to determine the signaling molecules involved in ET-1-stimulated
phosphorylation of extracellular signal-regulated kinases 1 and 2
(ERK1/2) in rat skeletal muscle (L6) cells. Methods: Change in the
phosphorylation level of ERK1/2 was analyzed by Western blot
experiment. Dominant negative dynamin (K44A) along with mono-
meric strawberry redﬂuorescent protein (RFP)was overexpressed in L6
cells using adenovirus-mediated gene transfer. Infection efﬁciency of
the adenovirus was determined by ﬂuorescence of RFP with ﬂow
cytometry. Results: ET-1 induced concentration-dependent phosphor-
ylation of ERK1/2 in L6 cells. The phosphorylation of ERK1/2 was
abolished by BQ-123 (a selective ETAR antagonist), YM-254890 (aGαq/
11 protein inhibitor), PD98059 (a mitogen-activated protein kinase/
ERK kinase 1/2 inhibitor), and AG370 (a platelet-derived growth factor
receptor (PDGFR) kinase inhibitor). The ERK1/2 phosphorylation in
response to ET-1was inhibited by overexpression of dominant negative
dynamin (K44A), which blocks clathrin-mediated endocytosis of cell
surface receptor. Conclusions: Gq/11 protein-coupled ETAR is involved
in the ET-1-induced phosphorylation of ERK1/2 in L6 cells. The ETAR-
mediated phosphorylation of ERK1/2 is dependent on transactivation of
PDGFR, which requires dynamin-dependent receptor internalization.
doi:10.1016/j.lfs.2013.12.137
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The current paradigm of G protein coupled receptor (GPCR)
signalling involves transactivation of protein tyrosine kinase receptors.
We utilised human vascular smoothmuscle cells (VSMC) to address the
question if a GPCR, the endothelin receptor, could transactivate a serine/
threonine kinase receptor, speciﬁcally the TGF-β receptor, TβRI.
Signalling molecules were assessed by Western blotting and proteo-
glycan synthesis by 35S-sulphate and 35S-Met/Cys incorporation and
molecular size by SDS-PAGE. Endothelin-1 treatment led to a time and
concentration dependent increase in cytosolic phosphoSmad2C which
was blocked by themixed endothelin receptor antagonist bosentan and
the TβRI antagonist SB431542. Endothelin-1 treatment led to a time-
dependent increase in nuclear phosphoSmad2C. Endothelin-1 stimu-
lated proteoglycan synthesis was partially blocked by SB431542 and
completely inhibited by bosentan. The effect of endothelin to stimulate
an increase in glycosaminoglycan size on biglycanwas also blocked in a
concentration-dependent manner by SB431542. These data extend the
current paradigm of GPCR signalling to include the transactivation of
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